ライフサイエンスコーパス: macular pigment

1 with missing central peak of photopigment or macular pigment.

2 n photopigment bleaching or on the amount of macular pigment.

3 coincides with the loss of Muller cells and macular pigment.

4 phyll levels, and the optical density of the macular pigment.

5 ong intake of xanthophylls and no detectable macular pigment.

6 ion because of their photo-oxidative role as macular pigment.

7 Lutein is a component of macular pigment.

8 m lutein supplementation can raise levels of macular pigment.

9 s the precursor of RSZ, a major component of macular pigment.

10 e consistent with the absorption spectrum of macular pigment.

11 RPE cells are sensitive to the absence of macular pigment.

12 eso-zeaxanthin are the major constituents of macular pigment, a compound concentrated in retinal area

13 Alterations were spatially related to macular pigment alterations but not to the presence of s

14 ge-related decline in the optical density of macular pigment among volunteers with no ocular disease

15 n cone photopigment distribution to those of macular pigment and examine those loci for subretinal ch

16 relationship between the spatial profile of macular pigment and foveal architecture.

17 n of the role for SCARB1 in the transport of macular pigment and the possible modulation of age-relat

18 Macular pigment and visual sensitivity of 27 healthy old

19 ns, determine absorption and distribution of macular pigment, and assess retinal health and visual fu

20 sity, spatial profile, and lateral extent of macular pigment, and it has been suggested that foveal a

21 ze contributions of extraneous fluorophores, macular pigment, and melanin, all measurements used exci

22 All premature infants had undetectable macular pigment, and most had unusually low serum and sk

23 anthin, the major carotenoids comprising the macular pigment, are present in rod outer segment (ROS)

24 The macular pigment can be increased in primates by either i

25 While the role of the macular pigment carotenoids in the prevention of age-rel

26 Deposition of the macular pigment carotenoids lutein and zeaxanthin in the

27 s yellow in color due to the presence of the macular pigment, composed of two dietary xanthophylls, l

28 e, and 1 individual (6%) exhibited decreased macular pigment contrast.

29 Loss of macular pigment, cystoid spaces, pigment plaques, neovas

30 Reliable and meaningful measurements of macular pigment density in older subjects can be made us

31 mine what personal characteristics influence macular pigment density in that sample.

32 There was a slight tendency for macular pigment density in this sample to decline with a

33 umber of individuals in this sample with low macular pigment density motivates the need for populatio

34 Macular pigment density of 30 subjects (age range, 16-60

35 The average macular pigment density was 0.22 +/- 0.13.

36 Macular pigment density was lower than average levels ob

37 Macular pigment density was measured psychophysically wi

38 The relation of smoking to macular pigment density was only significant for those c

39 Average macular pigment density was significantly lower in women

40 However, subjects with high or low macular pigment density were distinguished clearly.

41 sensitivity across the central field follows macular pigment density; (iii) polarization patterns are

42 ea of Muller's cell loss matches the area of macular pigment depletion.

43 a more important role than lutein status in macular pigment deposition in utero.

44 Distribution profiles of macular pigment did not change in response to supplement

45 otective, whereas individuals with a "foveal macular pigment dip" (FMPD) are at increased risk.

46 udy, macular pigment optical density (MPOD), macular pigment distributions, and skin carotenoid level

47 s (FA) (44.4% vs 12.5%, P = .03), absence of macular pigment epithelium atrophy on FA (88.9% vs 62.5%

48 ced absorption of 532 nm and 787 nm light by macular pigment, foveal sparing was more readily demonst

49 mparable to that for L and M cones, and that macular pigment has no significant function in improving

50 patterns follows the spectral sensitivity of macular pigment; (ii) the change in sensitivity across t

51 This study was designed to assess macular pigment in a high-light environment and to deter

52 ids, and vitamins to increase the density of macular pigment in first-generation offspring of parents

53 We used blue light reflectance to image the macular pigment in premature babies at the time of retin

54 Increasing evidence implicates macular pigment in protecting the retina and retinal pig

55 , is available regarding "average" levels of macular pigment in the general population.

56 tenuator, compatible with the arrangement of macular pigments in Henle fibres; (ii) the morphology of

57 ic method for the noninvasive measurement of macular pigments in the human retina.

58 plasma as well as the optical density of the macular pigment increased significantly in the groups ra

59 epidemiological evidence that the amount of macular pigment is inversely associated with the inciden

60 ization, differential absorption of light by macular pigments is perceived as the entoptic phenomena

61 aternal carotenoid status and newborn infant macular pigment levels and systemic carotenoid status.

62 in prenatal supplementation can raise infant macular pigment levels and/or improve ocular function.

63 The macular pigment levels are associated with inner retinal

64 We measured infant macular pigment levels using noninvasive blue light refl

65 The clinically recorded region of macular pigment loss in the macula correlated well with

66 Inferential evidence indicates that macular pigments (lutein and zeaxanthin) protect photore

67 Macular pigment measured with the LED tabletop device in

68 r understanding why some clinical methods of macular pigment measurement have had difficulty detectin

69 OCT scans and macular pigment measures were also recorded.

70 lature, small yellow macular deposits and/or macular pigment mottling, and abnormal electroretinogram

71 Ocular findings were focal macular pigment mottling, chorioretinal atrophy with a p

72 as designed to determine the heritability of macular pigment (MP) augmentation in response to supplem

73 Schultze, in 1866, originally proposed that macular pigment (MP) could improve acuity by reducing th

74 s investigated how individual differences in macular pigment (MP) density are related to loss of visu

75 Recent data on macular pigment (MP) have shown that screening the fovea

76 n these variables and the optical density of macular pigment (MP) in a group of subjects from a north

77 To determine macular pigment (MP) in patients with inherited retinal

78 that cross the blood-retina barrier to form macular pigment (MP) in the eye.

79 Macular pigment (MP) is composed of the xanthophylls lut

80 Macular pigment (MP) is composed of the yellow, blue-abs

81 Macular pigment (MP) is composed of two dietary caroteno

82 c flicker photometry was used to measure the macular pigment (MP) levels of 169 healthy volunteers, o

83 Skin carotenoid (SC) and macular pigment (MP) levels were measured with reflectio

84 lutein (L) and zeaxanthin (Z) that form the macular pigment (MP) may help to prevent neovascular age

85 To determine macular pigment (MP) optical density (OD) in patients wi

86 Psychophysical methods of measuring macular pigment (MP) use comparisons of short- and midwa

87 The association of macular pigment (MP) with age-related macular degenerati

88 of fluorescent lipofuscin, light-attenuating macular pigment (MP), cone photopigment, and retinal pig

89 For MacTel patients, macular pigment (MP), OCT, blue light reflectance, fluor

90 erties of PP and the spatial distribution of macular pigment (MP)?

91 Increasing evidence indicates that the macular pigments (MP) protect the central retina and may

92 macular region of the retina (referred to as macular pigment [MP]).

93 The optical density of macular pigment (MPOD) was measured in two male subjects

94 ein is a hydroxy-carotenoid constituting the macular pigment of the human retina.

95 Because the macular pigment of the retina is largely derived from 2

96 lutein, zeaxanthin, and omega-3 LCPUFAs and macular pigment optical densities were measured at basel

97 ital video fundus camera (RetCam) to measure macular pigment optical density (MPOD) and distributions

98 a high dose lutein/zeaxanthin supplement on macular pigment optical density (MPOD) and skin caroteno

99 a-3 polyunsaturated fatty acids may increase macular pigment optical density (MPOD) and thereby prote

100 supplementation with lutein (L) capsules on macular pigment optical density (MPOD) and visual acuity

101 To report the macular pigment optical density (MPOD) findings at 0.5 d

102 and to quantify the regional differences of macular pigment optical density (MPOD) in MacTel Type 2.

103 High foveal macular pigment optical density (MPOD) is protective, wh

104 1585 of 2005 CAREDS participants had macular pigment optical density (MPOD) measured noninvas

105 Macular pigment optical density (MPOD) measurements usin

106 Macular pigment optical density (MPOD) models enhance un

107 tudy evaluated serum lutein, zeaxanthin, and macular pigment optical density (MPOD) responses at 0.25

108 The spatial profile of macular pigment optical density (MPOD) was measured by c

109 Macular pigment optical density (MPOD) was measured by h

110 In this approved ancillary study, macular pigment optical density (MPOD), macular pigment

111 retinal circulation in three dimensions, and macular pigment optical density (MPOD), which quantifies

112 A subset of 16 infants was imaged for macular pigment optical density (MPOD).

113 (800 mg/d) on their serum concentrations and macular pigment optical density (MPOD).

114 a significant relation between variation in macular pigment optical density and immediate effects on

115 Macular pigment optical density was measured psychophysi

116 Although macular pigment optical density was significantly lower

117 tities of L and Z in the retina (measured as macular pigment optical density, MPOD).

118 on on concentrations of retinal carotenoids (macular pigment, or MP) is of particular interest becaus

119 significantly associated with an absence of macular pigments, pale optic disc, and periphery pigment

120 ees ) eccentricity, which is adjacent to the macular pigment peak, and parafoveally at 1.5 mm ( appro

121 gous nonsense mutations were associated with macular pigments, periphery pigments, and a high risk of

122 Because of the absence of macular pigment, phototoxic damage may then cause centra

123 By absorbing blue-light, the macular pigment protects the underlying photoreceptor ce

124 One theory of macular pigment's (MP) presence in the fovea is to impro

125 tributions: central peak of photopigment and macular pigment, small foveal alterations, and broad dis

126 nrolled at the Moran Eye Center had MPOD and macular pigment spatial distributions measured by dual-w

127 er clinical factors (ocular media opacities, macular pigment, statistical interpretation, and related

128 Ophthalmologic examination revealed macular pigment stippling and optic nerve atrophy.

129 fore might represent a more potent source of macular pigments than green leafy vegetables like spinac

130 To estimate macular pigment values in macular telangiectasia (MacTel

131 of critical point eccentricities and central macular pigment volume with foveal avascular zone and fo

132 Macular pigment was mapped with 488-nm and 514-nm light.

133 Macular pigment was measured psychophysically for 13 sub

134 Macular pigment was measured with the tabletop device wi

135 distributions of foveal cone photopigment or macular pigment were found that varied among the subject

136 been proposed to explain the function of the macular pigment, which selectively absorbs short-wavelen

137 The macular pigment xanthophylls lutein (L) and zeaxanthin (